Composite hydrocolloid shells protect probiotics from gastric degradation while maintaining cell viability through extended storage periods.
Cyclodextrin hosts enable reloadable drug reservoirs, resolving chronic treatment limits without increasing device complexity.
Consensus repeat design resolves low recombinant yield trade-offs while maintaining selective filtering capability in synthetic hydrogels.
Topical ingenol-3-angelate activates protein kinase C to eliminate HPV-induced warts without scarring or pigmentation changes.
Whitened turmeric syrup traps viruses in the throat, preventing airway dissemination without medical intervention side effects.
Lower dosage imiquimod formulations reduce application site reactions and systemic exposure while maintaining therapeutic efficacy for genital warts.
Topical analgesic formulation combines synergistic snake venoms with transdermal permeation enhancers to resolve toxicity and delivery trade-offs.
Chitosan polysiloxane composite solidifies in the teat canal to block pathogens without antibiotic withholding periods.
Dynamic bioreactors produce 3D brain organoids to harvest extracellular vesicles with enhanced therapeutic cargo profiles.
Ground antiviral powders mixed with local anesthetics in a cream base improve stability and reduce adverse effects.